Vasomotor Symptoms
54
6
7
35
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
14 trials with published results (26%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.6%
3 terminated out of 54 trials
92.1%
+5.6% vs benchmark
31%
17 trials in Phase 3/4
40%
14 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 35 completed trials
Clinical Trials (54)
Hormone thERapy Effects on BRAin-HEART Health During the Menopausal Transition
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
Goji Berry and Vasomotor Symptoms Pilot Study
A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)
Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong
Vasomotor Symptoms in Post-Hysterectomy Women With Ovarian Conservation
Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms
Efficacy of CL25216 on Vasomotor Symptoms in Women During Perimenopause
JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).
Stellate Ganglion Blockade in Post-Menopausal Women
A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)
Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women
A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause